Figure (Figure1)
Levetiracetam Solution
Product Images NDC 69452-412
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 69452-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Figure2)
Figure (Figure3)
Figure (Figure4)
This is a statistical data showing the percentages 44.6% and 19.6%, related to a study involving a Placebo group (X = 97) and a Levetiracetam group (N = 101). The figures appear to represent the distribution or results of the study between the two groups. This information could be part of a research or clinical trial report.*
Figure (Figure5)
Figure (Figure6)
Image Description (Image01)
This information provides details about Levetiracetam Oral Solution, USP, with each mL containing 100 mg of levetiracetam. The product comes in a 16 fl oz (473 mL) bottle and has specific storage recommendations. Users are advised to consult the package insert for dosage instructions and to keep the medication out of reach of children. The product is distributed by Bionpharma Inc. and has a pharmacist's note to dispense with caution in a secure container with a child-resistant closure. Additional contact information for reporting adverse events is provided. The product is made in India.*
Structure (Structure01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
